Based on the company's latest reports for March 2026, the current 12-month EPS is $6.08. Encompass Health's earnings per share in 2025 was reported at $5.62, marking a rise from $4.53 in 2024. In the quarterly report ending on Mar 31, 2026, EHC's earnings per share amounted to $1.96.
Encompass Health had an yealy earnings per share of $5.62, showing a rise of 24.1% from $4.53 recorded in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was $1.96, showing a 30.7% increase compared to the same quarter last year. The trailing twelve months EPS for EHC is $6.08 as of March 2026. Encompass Health's full-year EPS for 2024 was $4.53, a 29.1% rise compared to the previous year.
In the past 12 months, Encompass Health has recorded an earnings per share growth rate of 30.7% (YoY, quarterly). Over an extended period, the company registered an average EPS annual growth rate of 27.4% per year during the last 3 years. In the last five years, the company had an average annual EPS growth of 14.4%. A ten-year view shows that EHC has seen an average earnings per share growth of 10.8% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| NUTX Nutex Health Inc | 9.99 | 8.8% | N/A | -16.2% |
| SEM Select Medical Holdings Corp | 15.56 | -30.1% | -1.9% | -9.7% |
| EHC Encompass Health Corp | 16.42 | 24.1% | 27.4% | 14.4% |
All data is based on quarterly TTM periods, unless otherwise specified.